Success Story records
Historicalarchived

Enzyme-Based Decontamination Technology for Organophosphorus Nerve Agents and Pesticides

RDEC EDGEWOOD CHEMICAL BIOLOGICAL CENTER

With an increasing need to respond quickly and efficiently to real-world threats such as a deliberate chemical warfare agent attack or accidental release of toxic industrial chemicals, the U.S. Army Edgewood Chemical Biological Center (ECBC) developed a patented technology to neutralize organophosphorus chemical agents and pesticides. This enzyme-based technology simplifies and improves the process of decontaminating a class of highly toxic chemicals, including nerve agents. Other decontamination methods use corrosive chemicals that are more costly, less efficient, and generate a substantial amount of residual waste. The ECBC technology is nontoxic, noncorrosive, and environmentally safe. It can be applied using existing water-based application systems such as firefighting foams and sprays, and aircraft deicing solutions. In an incident where highly toxic chemicals are released, the enzymes quickly neutralize the chemicals before they can contaminate a wider area.

Applications

  • Military and Commercial Significance:
  • While initially intended for decontaminating
  • equipment, facilities and large
  • areas, the enzymes could potentially
  • be used in shower systems for decontaminating
  • personnel and casualties.
  • Having invented this enzyme-based
  • decontamination technology, ECBC
  • needed a commercialization partner to
  • license and enhance the manufacturing
  • process to drive down the unit cost
  • of the material—an important requirement
  • for broad adoption of the technology.
  • Genencor International, Inc.,
  • the leading manufacturer of industrial
  • and specialty enzymes in the United
  • States, was contacted to explore the
  • possibility of licensing and manufacturing
  • the technology. Genencor agreed
  • to license the technology and use its
  • state-of-the-art fermentation plants for
  • the manufacturing process.
  • Genencor met its production milestone
  • and is now successfully producing the
  • licensed enzymatic decontamination
  • technology under the trademark DEFENZ
  • ™. This product is being purchased
  • by companies that produce
  • and sell firefighting foams and sprays
  • and other matrices. These companies,
  • in turn, are formulating the enzymes
  • into products for purchase by
  • fire departments, HAZMAT groups,
  • and others in the first responder community.
  • The first commercial decontaminant
  • that incorporates the enzymes
  • (All-Clear™) was introduced
  • into the market by Kidde Fire Fighting,
  • Inc., in August 2005.

Provenance

Original
https://dodtechmatch.com/dod/successstories/view.aspx?id=60189

This record was recovered from a public web archive of dodtechmatch.com and is preserved for historical reference. It may be outdated. Not affiliated with the U.S. Department of Defense. Contact details from the original listing have been withheld.